RESEARCH-USE BIOSIMILAR ANTIBODY

Etesevimab

Monoclonal antibody · IgG1

SARS-CoV-2 Spike RBDIgG1RUO

Etesevimab (JS016) is a recombinant neutralizing human IgG1 anti-SARS-CoV-2 monoclonal antibody.

TARGETSARS-CoV-2 Spike RBD
YMonoclonal antibody
CATALOGSC-BS-558
CATALOG NUMBERSC-BS-558
MOLECULAR WEIGHTApprox. 145.18 kDa
PRODUCT FORMATMonoclonal antibody

A research-use configuration for comparative antibody studies

Etesevimab (JS016) is a recombinant neutralizing human IgG1 anti-SARS-CoV-2 monoclonal antibody.

Etesevimab is a recombinant research-use antibody directed against SARS-CoV-2 Spike RBD.

START A CONVERSATION

Tell us about your research goals.

For quotes, sample requests or technical support, start with your target and experimental context.

Contact StellaCyte
Etesevimab | StellaCyte